The Senate health committee on Nov. 20 will hold a confirmation hearing for FDA commissioner nominee Stephen Hahn, who is currently chief medical executive of MD Anderson Cancer Center. Committee Chair Sen. Lamar Alexander’s (R-TN) office announced the hearing Wednesday (Nov. 6) after a meeting between the lawmaker and nominee. Alexander described Hahn as well-qualified to lead the agency, saying he recognizes the importance of bringing new, lifesaving drugs and devices quickly through the regulatory process and understands the need...